CORPORATE NEWS
NEWSROOM
-
Recent Corporate News
-
2010 Corporate News
Dec. 02, 2010 Merck to Acquire SmartCells, Inc. Nov. 30, 2010 Merck Board Elects Kenneth C. Frazier as Next CEO; Richard T. Clark to Continue as Chairman Nov. 23, 2010 Merck Announces First-Quarter 2011 Dividend Nov. 19, 2010 Merck Wins Another Federal FOSAMAX® (alendronate sodium) Bellwether Trial Nov. 09, 2010 Merck Wins TEMODAR® Patent Infringement Lawsuit on Appeal Oct. 28, 2010 Statement on FOSAMAX® (alendronate sodium) Product Liability Trial in U.S. District Court Oct. 13, 2010 Weight Watchers and Merck Collaborate to Help Physicians Fight Obesity Through Lifestyle Management Approach Oct. 13, 2010 Tenth Edition of The Merck Veterinary Manual Debuts Oct. 12, 2010 Lundbeck and Merck Sign Exclusive Commercialization Agreement for SYCREST® (asenapine) Sublingual Tablets in All Markets Outside of the United States, China and Japan Oct. 04, 2010 Merck to Appeal Reduced Jury Verdict in Federal FOSAMAX® (alendronate sodium) Case Sep. 30, 2010 Merck to Appeal Verdict in Massachusetts Medicaid Case Sep. 29, 2010 Why So Shy? What Females of the Facebook Generation Are Not Sharing in the OB/GYN Office that Could Affect Their Health Sep. 22, 2010 Merck Significantly Expands its Patient Assistance Program Offerings to Provide Access to More Medicines for People in Need Aug. 10, 2010 Black AIDS Institute, in Partnership with Merck, Launches Dynamic National HIV/AIDS Treatment and Care Advocacy Network Jul. 27, 2010 Merck Grants License to LabCorp for Development of Test To Potentially Identify Patients Likely to Respond to Hepatitis C Therapy Jul. 27, 2010 Sanofi-aventis and Merck Appoint Raul Kohan as CEO for the New Animal Health Joint Venture Jul. 27, 2010 Sinopharm and Merck Sign Statement of Mutual Intent Jul. 08, 2010 Merck Details Plans to Advance Integration of R&D, Manufacturing and Business Operations Worldwide Jun. 29, 2010 Merck Wins Case Filed by Louisiana Attorney General Involving VIOXX® Jun. 25, 2010 Merck Challenges Verdict in Federal FOSAMAX® (alendronate sodium) Trial Aug. 10, 2010 Black AIDS Institute, in Partnership with Merck, Launches Dynamic National HIV/AIDS Treatment and Care Advocacy Network Jun. 24, 2010 Merck to Expand Business in South Africa Jun. 21, 2010 Merck and Codexis Honored with Presidential Green Chemistry Challenge Award for Novel Process for Sitagliptin Synthesis Jun. 07, 2010 Statement on FOSAMAX® (alendronate sodium) Product Liability Trial in U.S. District Court May 11, 2010 Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy for Growth in Emerging Markets May 11, 2010 Merck Highlights Robust Late-Stage Pipeline, Global Business Strategy and Progress of Integration May 10, 2010 Merck Settles Patent Infringement Case for Zetia® (ezetimibe) May 05, 2010 Merck Wins Second Federal FOSAMAX® (alendronate sodium) Bellwether Trial Apr. 28, 2010 Merck Announces Senior Management Appointments Apr. 27, 2010 U.S. Supreme Court Affirms Lower Court Decision on Merck Federal Securities Class Action Apr. 26, 2010 Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas® in Europe and Canada Apr. 21, 2010 Merck Obtains Exclusive Rights to Market and Distribute MassBiologics' Tetanus-Diphtheria (Td) Vaccine in the U.S. Apr. 19, 2010 Merck Statement on FOSAMAX® (alendronate sodium) Product Liability Trial in U.S. District Court Apr. 12, 2010 Statement on Vioxx® Consumer Product Trial in U.S. District Court for the Eastern District of Louisiana. Mar. 09, 2010 Statement by Merck & Co., Inc., Regarding FOSAMAX® (alendronate sodium) and Rare Cases of Osteonecrosis of the Jaw Mar. 09, 2010 Sanofi-aventis and Merck to create a Global Leader in Animal Health Mar. 04, 2010 Merck Statement on Vioxx® Judgment in Australia Mar. 01, 2010 AstraZeneca Exercises Option to Acquire Merck's Interest in Partnership Products Feb. 15, 2010 Merck Appoints Bridgette P. Heller As Executive Vice President and President, Consumer Health Care
The information contained in each news release posted on this page was factually accurate on the date it was issued. The company assumes no duty to update the information to reflect subsequent developments. Readers of the news releases should not rely upon the information as current or accurate after their issuance dates.
-
Patients & Caregivers
-
Healthcare Professionals
-
Media & Investors
-
Job Seekers
-
Company Statements
- Copyright © 2009-2011 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
- Privacy
- Terms of Use
- Site Map
